Students Vs Pandemics COVID-19 Podcast

In this episode of our monthly podcast, we discuss the current recommendations for booster vaccinations for COVID-19.

In this episode of our monthly podcast, we detail a brief overview of the August 2021 developments in relation to the Delta variant of COVID-19.

This episode of the SvP podcast answers everything there is to ask about vaccine hesitancy. What is the history? What diseases have and haven't been eradicated by vaccines? What populations are most likely to exhibit hesitance? And why? Are unvaccinated Americans still wearing masks indoors? How about the current prospects of reaching herd immunity? 

These issues and many more are addressed in this very topical SvP podcast episode. 

Long-COVID has become a widely reported phenomenon, as researchers find evidence of COVID-19 survivors suffering negative effects to multiple organ systems. However, mental and neurological health are often overlooked in favor of "more physical" conditions. 

In this episode of our Harvard Chapter's monthly podcast, we explore the kinds of long term neuropsychiatric complications patients may be facing, how commonly these symptoms occur, as well as how SARS-CoV-2 may be causing these complications in the first place. 

In this episode of the SvP podcast, we delve into the causes of India's current, devastating COVID outbreak. We discuss how current numbers may be under-reported, the WHO's statement on the crisis, as well as a review of other nations' aid to India. We conclude with a discussion of the mutations and possible immune evasion techniques of India's B.1.617 variant.  

In this episode of the SvP podcast, we provide a discussion of each of the CDC's "SARS-CoV-2 Variants of Concern", as well as the recent New York/New Jersey B.1.526 strain. After describing the mutations and attributes of these viral strains, we conclude with a summary of the pandemic and vaccination efforts through the month of March.

Transcript is available at: tinyurl.com/FebScript

In this episode we give a review of the state of the pandemic in February and we also explore COVAX, which was established to ensure equality in vaccine distribution. Finally, we note the disparities that exist between developing nations and wealthier countries, in reference to the purchase of vaccine doses from pharmaceutical companies. 

Welcome to the SvP podcast! In this first episode, we begin with a brief overview of the current data associated with the coronavirus pandemic, before explaining the challenges of vaccine delivery and the workarounds pharmaceutical companies have created. Finally, we address the future of mRNA vaccine therapies, beyond the current pandemic.